Document Detail

Drug-Eluting Stenting of Saphenous Vein Graft Versus Native Coronary Artery Supplying the Same Myocardial Perfusion Territory: A Pilot Retrospective 3-Year Follow-up.
MedLine Citation:
PMID:  23043035     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: In post-coronary artery bypass graft (CABG) patients undergoing drug-eluting stent implantation of either the saphenous vein graft (SVG) versus the native coronary artery supplying the same myocardial perfusion territory, which option confers better clinical outcomes when both lesions are technically feasible?
METHODS: From 2005 to 2008 at a single medical center, a total of 178 post-CABG patients (with 241 lesions) underwent PCI due to progressive SVG disease. Of them, 23 patients (with 29 lesions) had amenable disease for PCI in both the SVG and native coronary artery matching the same myocardial perfusion territory; chronic total occlusions were excluded. All patients included in the study were treated with drug-eluting stents. Sixteen patients (19 lesions) underwent PCI of the SVG, and 9 patients (10 lesions) underwent PCI in the native vessels.
RESULTS: Primary endpoints were in-hospital and 3-year rates of death, myocardial infarction (MI), target lesion revascularization (TLR), and target vessel revascularization (TVR). There were 2 in-hospital MIs in the SVG-treated group and 0 for the native vessel-treated group. The 3-year clinical follow-up showed 3 MIs, 2 TLRs, 4 TVRs, and 6 deaths in the SVG-treated group; only 1 MI occurred in the native-vessel treated group (P=.02). More PCIs of the SVG were performed than in the native coronary artery (19 vs 10 lesions).
CONCLUSIONS: This small study suggests improved clinical outcomes with PCI of the native vessel, but a tendency of operators to choose PCI of the SVG instead. Large, prospective, multicenter, randomized clinical trials with long-term follow-up can validate the advantage of selecting PCI of the native vessel over the SVG when both options are available.
Paul C Ho; Arthur C Lee; Richard Fortuna
Related Documents :
8678085 - Resting electrocardiographic abnormalities as predictors of coronary events and total m...
624315 - The loss of electrically active myocardium in cardiogenic shock.
23027595 - Is surgery the gold standard in the treatment of obstructive hypertrophic cardiomyopathy?
90965 - Effect of atenolol on recovery of the electrocardiographic signs of myocardial infarction.
17276955 - Comparison of simultaneous antegrade/vein graft cardioplegia with antegrade cardioplegi...
11326145 - Effect of ascorbic acid on endothelial dysfunction of epicardial coronary arteries in c...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of invasive cardiology     Volume:  24     ISSN:  1557-2501     ISO Abbreviation:  J Invasive Cardiol     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8917477     Medline TA:  J Invasive Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  516-20     Citation Subset:  IM    
Division of Cardiology, Hawaii Region Kaiser Permanente, 3288 Moanalua Road, Honolulu, HI 96819 USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Gore helex septal occluder for percutaneous closure of patent foramen ovale associated with atrial s...
Next Document:  Effect of intensive atorvastatin therapy on coronary atherosclerosis progression, composition, arter...